These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31404728)

  • 1. A review of thrombotic microangiopathies in multiple myeloma.
    Portuguese AJ; Gleber C; Passero FC; Lipe B
    Leuk Res; 2019 Oct; 85():106195. PubMed ID: 31404728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
    Gavriilaki E; Anagnostopoulos A; Mastellos DC
    Front Immunol; 2019; 10():337. PubMed ID: 30891033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of TMA based on Japanese clinical guides].
    Wada H; Hasegawa K; Watanabe M
    Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange.
    Sullivan MR; Danilov AV; Lansigan F; Dunbar NM
    J Clin Apher; 2015 Oct; 30(5):308-10. PubMed ID: 25413611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
    Hanna RM; Henriksen K; Kalantar-Zadeh K; Ferrey A; Burwick R; Jhaveri KD
    Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CME: Diagnostic Approach and Management of Thrombotic Microangiopathy].
    Sutter T; Fehr T; Venzin R
    Praxis (Bern 1994); 2022; 111(14):771-777. PubMed ID: 36285415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
    Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
    Scully M; Rayment R; Clark A; Westwood JP; Cranfield T; Gooding R; Bagot CN; Taylor A; Sankar V; Gale D; Dutt T; McIntyre J; Lester W;
    Br J Haematol; 2023 Nov; 203(4):546-563. PubMed ID: 37586700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments.
    Chapin J; Shore T; Forsberg P; Desman G; Van Besien K; Laurence J
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):565-73. PubMed ID: 25654478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy and indications for therapeutic plasma exchange.
    Adamski J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):444-9. PubMed ID: 25696892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathies: from animal models to human disease and cure.
    Caprioli J; Remuzzi G; Noris M
    Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition.
    Catanese L; Link K; Rupprecht H
    BMC Nephrol; 2023 Jun; 24(1):179. PubMed ID: 37337151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.